Chronic Lymphocytic Leukemia: What Patients Should
Know

Chronic lymphocytic leukemia or CLL accounts for 25% of all
leukemias in the U.S., most common in adults over 50. It affects certain
white blood cells called lymphocytes with s...
Time: 06:48 minutes
Will Targeted Therapies Work for CLL?

Initially approved for specific types of non-Hodgkin's
lymphoma, the monoclonal antibody Rituxan is now being used by to treat
Chronic Lymphocytic Leukemia or CLL. At a rec...
Time: 08:58 minutes
Rituxan: Not Just for Cancer?

Rituxan is a monoclonal antibody therapy that was approved
several years ago for specific types of non-Hodgkin's lymphoma .
At the 2001 American Society for Hematology meet...
Time: 07:12 minutes